BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 19840853)

  • 1. Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.
    Lim ST; Airavaara M; Harvey BK
    Pharmacol Res; 2010 Jan; 61(1):14-26. PubMed ID: 19840853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors in neurodegeneration.
    Blesch A
    Brain Pathol; 2006 Oct; 16(4):295-303. PubMed ID: 17107599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant gene therapy against neuronal cell death.
    Navarro-Yepes J; Zavala-Flores L; Anandhan A; Wang F; Skotak M; Chandra N; Li M; Pappa A; Martinez-Fong D; Del Razo LM; Quintanilla-Vega B; Franco R
    Pharmacol Ther; 2014 May; 142(2):206-30. PubMed ID: 24333264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases.
    Nam Y; Moon GJ; Kim SR
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives.
    El Ouaamari Y; Van den Bos J; Willekens B; Cools N; Wens I
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repairing the parkinsonian brain with neurotrophic factors.
    Aron L; Klein R
    Trends Neurosci; 2011 Feb; 34(2):88-100. PubMed ID: 21144600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
    Kelly MJ; O'Keeffe GW; Sullivan AM
    Expert Rev Mol Med; 2015 May; 17():e8. PubMed ID: 25997719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration.
    Madduri S; Gander B
    J Peripher Nerv Syst; 2010 Jun; 15(2):93-103. PubMed ID: 20626772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
    Lundberg C; Björklund T; Carlsson T; Jakobsson J; Hantraye P; Déglon N; Kirik D
    Curr Gene Ther; 2008 Dec; 8(6):461-73. PubMed ID: 19075629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
    Joshi CR; Labhasetwar V; Ghorpade A
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders.
    Lanni C; Stanga S; Racchi M; Govoni S
    Curr Pharm Des; 2010; 16(6):698-717. PubMed ID: 20388080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord.
    Hendriks WT; Ruitenberg MJ; Blits B; Boer GJ; Verhaagen J
    Prog Brain Res; 2004; 146():451-76. PubMed ID: 14699980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
    Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
    Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatile somatic gene transfer for modeling neurodegenerative diseases.
    Klein RL; Wang DB; King MA
    Neurotox Res; 2009 Oct; 16(3):329-42. PubMed ID: 19669852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating the therapeutic potential of neurotrophic factors to clinical 'proof of concept': a personal saga achieving a career-long quest.
    Bartus RT
    Neurobiol Dis; 2012 Nov; 48(2):153-78. PubMed ID: 22525569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.
    Parambi DGT; Alharbi KS; Kumar R; Harilal S; Batiha GE; Cruz-Martins N; Magdy O; Musa A; Panda DS; Mathew B
    Mol Neurobiol; 2022 Jan; 59(1):191-233. PubMed ID: 34655056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain.
    Bondarenko O; Saarma M
    Front Cell Neurosci; 2021; 15():682597. PubMed ID: 34149364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS gene therapy and a nexus of complexity: systems and biology at a crossroads.
    Tyler CM; Federoff HJ
    Cell Transplant; 2006; 15(3):267-73. PubMed ID: 16719061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking the knife to neurodegeneration: a review of surgical gene therapy delivery to the CNS.
    Perera A; Brock O; Ahmed A; Shaw C; Ashkan K
    Acta Neurochir (Wien); 2024 Mar; 166(1):136. PubMed ID: 38483631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes.
    Kumari S; Kamiya A; Karnik SS; Rohilla S; Dubey SK; Taliyan R
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38856793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.